LQDALiquidia Corporation
$42.62+84% 1Y
$42.62
$22.0252 weeks$91.06
Is the price fair?
What LQDA's price assumes
Liquidia Corporation trades at 30.7× earnings against 21.0× for the median Drug Manufacturers - Specialty & Generic name, more expensive than its own group.
30.7
Trailing P/E · Drug Manufacturers - Specialty & Generic median 21.0 · 1.46× the median: the market pays up for this one
- Price / sales
- 17.9
Price / sales · as of 2026-Q2
- Price / book
- 41.4
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 41.4
- Healthcare median P/E503 names
- 27.9
- Drug Manufacturers - Specialty & Generic median P/E44 names
- 21.0
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks
Drug Manufacturers, Specialty & Generic
The closest names by size in the same industry